Global Blood Screening Market 2020: Growth, Emerging Trends And Forecast By Beckman Coulter, Inc., Abbott , F. Hoffmann-La Roche Ltd , Cepheid , GRIFOLS INTERNATIONAL, S.A.
This blood screening report broadly encompasses absolute and distinct analysis of the market drivers and restraints, major market players involved in the healthcare industry, exhaustive analysis of the market segmentation, and competitive analysis of the key players. All the data and information involved in the blood screening report is taken from incredibly trustworthy sources such as websites, annual reports of the companies, white papers, journals, newspapers, and mergers. A number of estimations and calculations have been executed in this market analysis report by assuming definite base year and the historic year.
Competitive Analysis: Global Blood Screening Market
Some of the prominent participants operating in this market are Enzo Biochem Inc., Meridian Bioscience, Inc. , BD , Bio-Rad Laboratories, Inc. , Thermo Fisher Scientific Inc., BioMérieux SA, Beckman Coulter, Inc., Abbott , F. Hoffmann-La Roche Ltd , Cepheid , GRIFOLS INTERNATIONAL, S.A. , Siemens AG , Ortho Clinical Diagnostics , Immucor, Inc., Hologic Inc., among others.
Get Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-blood-screening-market
Segmentation: Global Blood Screening Market
Global blood screening market is categorized based on basis of products & services, technology, disease type and end user.
On the basis of product & services the market is segmented into reagents and kits, instruments and software & services. Reagents and kits are further sub segmented into NAT reagents & kits, ELISA reagents & kits others as well. NAT reagents is further sub segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions alsolabeling and detection reagents. ELISA reagents & kits is further sub segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) also sample diluents and wash solutions. Instruments segment is further segmented into instruments, product types and instruments, purchase type. In 2017, reagents & kits segment is expected to dominate the global blood screening market growing at the CAGR of 9.4% in the forecast period of 2018 to 2025.
In January 2017, F. Hoffmann-La Roche Ltd launched haematology testing solution. This solution is called the cobas m 511 integrated haematology analyser. This launch marked the entry for Roche Diagnostics in the haematology market.
On the basis of technology the market is segmented into nucleic acid test, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS) and others. Nucleic acid test is further sub segmented into transcription-mediated amplification (TMA) and real-time polymerase chain reaction (PCR). Enzyme-linked immunosorbent assay (ELISA) is further segmented into ELISA market, by platform, ELISA market, by generation. ELISA Market, By Platform is further sub segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA) and colorimetric immunoassay (CI). ELISA market, by generation is further segmented into first-generation ELISA, second-generation ELISA, third-generation ELISA and fourth-generation and above. In 2017, enzyme-linked immunosorbent assay (ELISA) segment is expected to dominate the global blood screening market growing at the CAGR of 9.8% in the forecast period of 2018 to 2025.
In September 2018, Thermo Fisher Scientific Inc. (U.S.), signed a definitive agreement with BD This business combines a strong technical service program with a variety of media and other products. This acquisition helped company to expand their business on global level with larger number of products.
On the basis of disease type, the market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and others. In 2017, oncology segment is expected to dominate the global blood screening marketgrowing at the highest CAGR of 10.3% in the forecast period of 2018 to 2025.
In June 2018, Thermo Fisher Scientific (U.S.) launched Oncomine TCR Beta-SR Assay. It is a new next-generation sequencing (NGS) solution in the field of immuno-oncology research. This helped company to expand their business by enhancing their product portfolio.
On the basis of end user the market is segmented into hospitals, clinics, diagnostic centers, blood bank and ambulatory surgical cenetrs. In 2017, diagnostic centers segment is expected to dominate the global blood screening market growing at the highest CAGR of 10.4%in the forecast period of 2018 to 2025.
In September 2016, Siemens Healthineers (Germany) acquired Conworx Technology GmbH (Germany) for point-of-care device interfaces and data management solutions. The company’s products and solutions designed helped in increasing efficiency and to reduce costs.
In March 2018, Bio-Rad Laboratories, Inc. launched IncRNA Workflow, a RT-qPCR workflow which is used to optimized for highly sensitive and specific quantification of long noncoding RNAs (lncRNAs) for gene expression analysis. The workflow provides a streamlined, cost-effective alternative to RNA-Seq for lncRNA discovery and validation.
In June 2018, Thermo Fisher Scientific launched Oncomine TCR Beta-SR Assay. It is a new next-generation sequencing (NGS) solution in the field of immuno-oncology research. This helped company to expand their business by enhancing their product portfolio.
In September 2018, Thermo Fisher Scientific Inc. , signed a definitive agreement with BD This business combines a strong technical services program with a variety of media and other products. This acquisition helped company to expand their business on global level with larger number of products.
Drivers: Global Blood Screening Market
RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS:
Blood transfusion is an essential component of the health care field. It helps in saving millions of lives every year in both cases of routine and emergency conditions. Below mentioned are some of the statistics for blood donation and blood donors:
According to the World Health Organization (WHO), in 2017, it was reported that 112.5 million blood donations were collected from worldwide in which approximately half of the blood was collected from developed countries.
According to the World Health Organization (WHO), in 2017, it was reported that in 1000 people, the blood donation rate was 32.1 from high-income countries, 14.9 in upper-middle-income countries, 7.8 in lower-middle-income countries and 4.6 in low-income countries.
According to Australia Red cross blood service, 606,000 donors are there in Australia which are in 1,000 locations such as collection centres for blood donation available.
RISING PREVALENCE IN NUMBER OF DISEASES:
The prevalence of diseases and conditions such as Tuberculosis, HIV infection, Intestinal nematodes, diabetes mellitus, respiratory diseases, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and many others have increased considerably over a period of time. As numbers of diseases are increasing there is requirement for blood screening and diagnosis for further treatment of diseases.
According to WHO, alpha and beta thalassaemias are found to be the most common inherited single-gene disorders around the world. This disorder is with the highest prevalence with malaria at the places where it is endemic.As per the study conducted in Iran, it was estimated that approximately 8,000 pregnancies with risk takes place every year.
In 2016, according to Centers for Disease Control and Prevention (CDC), at the end of 2015, it was estimated 1.1 million persons with age 13 or older were suffering from HIV infection in the U.S. with an estimation of 162,500 (15.0%) persons whose infections had not been diagnosed.
In February 2018, according to verywell health, in South Africa 5,600,000 of people were estimated with HIV in 2009. In the total population of 53 million, the HIV prevalence for South Africa is found to be 10.6%.
Speak To Industry Experts, Request For Details Report At: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-blood-screening-market
Opportunity: Global Blood Screening Market
INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
The screening of blood involves the process that ensures whether the blood collected from people are safe or not. Based on the results of the screening, collected blood units are released for clinical research purpose or discarded if it has some contamination of bacteria or viruses or any other. For performing such screening there are different assays that help in determining the proper result.
Further with advancement, many of the other techniques are introduced with high benefits helping the market to grow in the upcoming days. The techniques are microbial screening and multiplexing technology.
Thermo Fisher Scientific (U.S.) provides microbial isolation and screening which include blood culture systems, clinical microbial identification, and microbiology specimen collection
In August 2015, Eurofins (France) launched accredited NGS tests useful for the identification of non-targeted microorganism. It helps in 16S rDNA screening for identifying the presence of microorganism communities in sample.
In July 2017, July 18, 2017–BD (Becton, Dickinson and Company) (U.S.) introduced new technologies which can automatically report and release negative urine cultures. This technology is transformed in the form of microbiology urine testing.
Data Bridge Market Research
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Blood Screening Market 2020: Growth, Emerging Trends And Forecast By Beckman Coulter, Inc., Abbott , F. Hoffmann-La Roche Ltd , Cepheid , GRIFOLS INTERNATIONAL, S.A. here
News-ID: 1904345 • Views: 80
More Releases from Data Bridge Market Research
Medical Coding Market Size, share 2021 Industry Growing Rapidly with Recent Dema …
DBMR added a comprehensive research document of 350+ pages on 'Global Medical Coding Market Share, Size, Industry Report’ with detailed insights on growth factors and strategies. The study segments key regions that includes North America, Europe, Asia-Pacific with country level break-up and provide volume and value related cross segmented information by each country. Medical Coding Industry report is to provide detailed analysis of the market structure along with forecast
Healthcare IT Outsourcing Market 2021 Covid-19 Impact Analysis on Global Industr …
The newly added report entitled Global Healthcare IT Outsourcing Market Size, Share, Growth, Industry Trends and Forecast to 2028 to the repository of Data Bridge Market Research features an extensive study on the market, exploring its key aspects. The report provides a thorough analysis of the current trends, opportunities, drivers, and restraints in the global Healthcare IT Outsourcing. The report concentrates on top players and their business tactics, geographical expansion,
AI in Drug Discovery Industry 2021 With Covid-19 Impact on Market Size, Industry …
The newly added report entitled Global AI in Drug Discovery Market Size, Share, Growth, Industry Trends and Forecast to 2028 to the repository of Data Bridge Market Research features an extensive study on the market, exploring its key aspects. The report provides a thorough analysis of the current trends, opportunities, drivers, and restraints in the global AI in Drug Discovery. The report concentrates on top players and their business tactics,
Wearable Fitness Trackery Market Analysis | Global Industry Analysis By Trends, …
Wearable Fitness Trackery Market 2021-2028 mainly presents value, growth, volume and market share by players, by size, by product type, by regions, by consumers and also their price change details. As an in depth Analysis report, it covers all key attributes analysis and opinion for Wearable Fitness Trackery industry. The research provides strategically important competitor insights to formulate effective RandD strategies. Likewise, the report reviews key companies involved in Wearable
More Releases for ELISA
Global Enzyme-linked Immunosorbent Assay (ELISA）Analyzers Market Research Repo …
This report studies the global Enzyme-linked Immunosorbent Assay (ELISA）Analyzers market status and forecast, categorizes the global Enzyme-linked Immunosorbent Assay (ELISA）Analyzers market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Thermo Fisher PerkinElmer Tecan BioTek EUROIMMUN DiaSorin BIO-RAD Molecular Devices Dynex Technologies BMG
Global ELISA Analyzers Market Research Report
This report studies the global ELISA Analyzers market status and forecast, categorizes the global ELISA Analyzers market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Thermo Fisher PerkinElmer Tecan BioTek EUROIMMUN DiaSorin BIO-RAD Molecular Devices Dynex Technologies BMG Labtech KHB Promega Trinity
Global ELISA Processors Market Research Report 2018
In this report, the global ELISA Processors market is valued at USD million in 2017 and is expected to reach USD million by the end of 2025, growing at a CAGR between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ELISA Processors in these regions, from 2013 to 2025 (forecast), covering
ELISA Analyzer Market trend, outlook 2025
Enzyme Linked Immunosorbent Assay (ELISA) is a biochemical assay, which use antibodies and an enzyme-mediated color change to detect the presence of either antigen (proteins, peptides, and hormones) or antibody in sample. Enzyme-linked immunosorbent assay is used as diagnostic tool in medicine and analytical tool in biomedical research. ELISA analyzer is an instrument used for detecting the concentration and presence of analyte in the test sample. ELISA analyzer can be
ELISA Reagents Market Research Report : 2017
Reports And Markets Publish a New Market Research Report On –" ELISA Reagents Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-elisa-reagents-market-research-report-2017-1541198 In this report, the global ELISA Reagents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key
Global ELISA Reagents Sales Market Report 2017
The Global ELISA Reagents Sales Market Report 2017 is a professional and in-depth study on the current state of the ELISA Reagents industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The ELISA Reagents market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost